News from Longeveron LLC A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 19, 2019, 09:05 ET Longeveron Discusses Latest Stem Cell Findings for Aging Frailty at the International Conference on Frailty & Sarcopenia Research

Longeveron LLC, a biopharmaceutical company that develops cellular therapies for aging-related diseases, will discuss the company's latest clinical...


Jan 18, 2019, 09:35 ET Longeveron Co-Chairs, Hosts Symposium At The 2019 World Stem Cell Summit And Phacilitate Leaders World Conferences In Miami

Longeveron LLC, a biopharmaceutical company that develops cellular therapies for aging-related diseases, will play a prominent role when leading...


Oct 29, 2018, 09:46 ET Longeveron Chief Science Officer Dr. Joshua Hare To Address 2018 TEDCO Stem Cell Symposium

Longeveron LLC, a biopharmaceutical company that develops cell therapies for aging-related diseases, announced that Joshua M. Hare, M.D., will be a...


Oct 18, 2018, 10:17 ET Longeveron Receives Prestigious NIH Small Business Innovation Research Grant

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company has been awarded ...


Oct 05, 2018, 09:40 ET Longeveron Chief Science Officer Dr. Joshua Hare To Keynote 2018 HEALinc Future Health Innovation Summit

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies, announced that Co-Founder and Chief Science Officer Joshua Hare, M.D....


Oct 03, 2018, 13:33 ET Longeveron To Present At The 2018 Cell & Gene Meeting On The Mesa

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company will present at...


Aug 29, 2018, 10:36 ET Longeveron Appoints Arin Maercks Chief Commercial Officer

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company has appointed...


Aug 20, 2018, 13:18 ET Longeveron Co-Authors Important ICSFR Task Force Paper On Aging Frailty

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the International Conference ...


Jul 13, 2018, 14:53 ET Dr. Joshua Hare To Present Longeveron Regenerative Stem Cell Research At The Sixth Annual Aspen BrainLab

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that Dr. Joshua Hare, Chief...


May 23, 2018, 09:49 ET Longeveron Recruiting for Stem Cell Alzheimer's Trial in South Florida

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for age-related diseases, announced that it is currently recruiting for ...


May 22, 2018, 09:29 ET Longeveron Receives TEDCO Grant To Fund Stem Cell Research

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related conditions, announced that it has received a $750,000 ...


Feb 27, 2018, 02:57 ET First Longeveron Mesenchymal Stem Cell Treatment Administered to an Infant with Rare Heart Condition as Part of Groundbreaking Clinical Trial

Longeveron announced that its pioneering clinical trial to treat infants with Hypoplastic Left Heart Syndrome officially started with the first...


Jan 23, 2018, 09:00 ET Longeveron Shares Promising State of Regenerative Medicine Research with Experts at the FDA, NIH and Other Leading Organizations at National Conference

The early results of mesenchymal stem cells studies look encouraging for lessening or reversing the effects of Aging Frailty, Joshua M. Hare, M.D.,...


Jan 22, 2018, 10:28 ET Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami

Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when investigators from around the globe converge...


Oct 17, 2017, 09:30 ET Longeveron Pioneering Development of Stem Cell Therapies for Aging Frailty

Longeveron LLC, a leading life sciences company developing innovative therapies for age-related diseases, announced that the company is progressing...


Sep 06, 2017, 08:47 ET Longeveron Initiates Phase 2b Stem Cell Therapy Trial to Treat Aging Frailty

Longeveron LLC, a regenerative medicine company developing cellular therapies, announced today that it treated its first patient in the Company's...


Jul 24, 2017, 09:22 ET Longeveron to Sponsor Industry Symposium on Regenerative Medicine at 2017 IAGG World Congress

Longeveron LLC is sponsoring a regenerative medicine symposium at the 2017 International Association of Gerontology and Geriatrics (IAGG) World...


May 15, 2017, 13:19 ET Longeveron Announces Publication of Phase 1 Safety and Efficacy Trial Results for Allogeneic Stem Cell Treatment in Frailty Patients

Longeveron LLC, a leading regenerative medicine company developing innovative therapies for age-related diseases, announced the publication of Phase...